Fosun Capital

Fosun Capital is a wholly-owned subsidiary of Fosun International and serves as its primary domestic private equity investment platform. It invests off the parent's balance sheet and draws on Fosun's industrial operations across healthcare, consumer, and financial services for deal sourcing and post-investment support. The platform's capital base is therefore directly tied to the conglomerate's own liquidity and strategic direction.

Fosun Capital's website describes coverage from seed and start-up venture rounds through growth equity, expansion, PIPE transactions, and pre-IPO placements. It does not publish a stage-concentration breakdown, so the mix across early-stage and late-stage vehicles is not publicly verifiable.

Fosun Capital does not name a chief investment officer or managing partner on its public-facing materials. Investment decisions are made internally under the governance of Fosun International, whose senior leadership — historically anchored by chairman Guo Guangchang — oversees capital allocation across the group's private equity activities.

As the captive private equity arm of a publicly listed conglomerate, Fosun Capital primarily manages proprietary capital. Whether the firm has raised third-party discretionary funds or co-investment vehicles is not disclosed in current publicly available materials.

The firm's investment mandate follows Fosun International's global footprint, with emphasis on China, Europe, and other markets where the parent operates industrial assets. Specific country or regional allocation data is not published at the private equity subsidiary level.